Several African countries do not have AstraZeneca vaccines to administer second doses after India bans exports due to the crisis.
Africa’s vaccination campaigns to combat COVID-19 are facing significant delays due to India’s export ban as it faces a devastating resurgence of the disease, the maximum said. African health official.
The AstraZeneca vaccine manufactured by the Serum Institute of India was to be an integral part of the COVAX initiative, supported by the United Nations, to distribute vaccines to low- and middle-income countries.
India’s deadly crisis and its decision to stop all vaccine exports it produces has severely affected Africa’s massive vaccine, which was already lagging behind many other parts of the world, said John Nkengasong, director of African Centers for Disease Control and Prevention. Thursday.
Several African countries had administered all the AstraZeneca vaccines they received, awaiting new deliveries in order to give people their second dose, Nkengasong said in his weekly report.
But as a result of India’s export ban, these countries do not have AstraZeneca vaccines to give people their second doses.
“There is a likelihood that, given what is happening in India, there is a significant delay,” said Nkengasong, who suggested the use of other vaccines.
“Countries should look for options on how to get Johnson & Johnson vaccines available through the African Union Vaccine Procurement Task Force as an alternative, which is a single-dose vaccine,” he said. .
The mainland has more than 4.7 million confirmed cases of infections, including 127,000 deaths since the outbreak of the virus, which accounts for 3 percent of global infections and 4 percent of global deaths, Nkengasong said.
South Africa, Morocco, Tunisia, Ethiopia and Egypt together account for about 60 percent of all infections recorded on the continent.
Just over 56,000 cases were reported last week, a 6% decrease in new infections compared to the previous week, he said.
Nkengasong said nine African countries have detected the variant that is now dominant in India.
“The way this virus circulates and transmits suggests that it is a matter of time before this variant spreads more widely across the continent,” Nkengasong said.